Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Lung Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Medicine & Life Sciences
Mutation Medicine & Life Sciences
Insulin Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Adenosine Triphosphate Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2002 2017

  • 431 Citations
  • 10 h-Index
  • 21 Article
  • 5 Review article
Fluorodeoxyglucose F18
Non-Small Cell Lung Carcinoma
Positron-Emission Tomography
lesions
Neoplasms

Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer

Hardin, C., Shum, E., Singh, A., Perez-Soler, R. & Cheng, H. May 3 2017 In : Expert Opinion on Pharmacotherapy. 18, 7, p. 701-716 16 p.

Research output: Contribution to journalReview article

Tubulin Modulators
Non-Small Cell Lung Carcinoma
Paclitaxel
Immunotherapy
Biological Markers
1 Citations
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Neoplasms
Lung
Immunotherapy

Investigational therapies for squamous cell lung cancer: from animal studies to phase II trials

Shum, E., Wang, F., Kim, S., Perez-Soler, R. & Cheng, H. Apr 3 2017 In : Expert Opinion on Investigational Drugs. 26, 4, p. 415-426 12 p.

Research output: Contribution to journalReview article

Squamous Cell Neoplasms
Lung Neoplasms
Immunotherapy
Cytotoxins
Expert Testimony
1 Citations

Emerging treatment for ALK-positive lung cancer

Sharma, J., Pareek, V., Liu, H. & Cheng, H. Apr 2 2016 In : Expert Opinion on Emerging Drugs. 21, 2, p. 147-155 9 p.

Research output: Contribution to journalReview article

Lung Neoplasms
Non-Small Cell Lung Carcinoma
Biopsy
Oncogene Fusion
Immunotherapy